260 related articles for article (PubMed ID: 26420673)
1. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis.
Hu D; Gur M; Zhou Z; Gamper A; Hung MC; Fujita N; Lan L; Bahar I; Wan Y
Nat Commun; 2015 Sep; 6():8419. PubMed ID: 26420673
[TBL] [Abstract][Full Text] [Related]
2. A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy.
Zhou Z; Feng Z; Hu D; Yang P; Gur M; Bahar I; Cristofanilli M; Gradishar WJ; Xie XQ; Wan Y
EBioMedicine; 2019 Jun; 44():98-111. PubMed ID: 31101597
[TBL] [Abstract][Full Text] [Related]
3. Methylation of the central transcriptional regulator KLF4 by PRMT5 is required for DNA end resection and recombination.
Checa-Rodríguez C; Cepeda-García C; Ramón J; López-Saavedra A; Balestra FR; Domínguez-Sánchez MS; Gómez-Cabello D; Huertas P
DNA Repair (Amst); 2020 Oct; 94():102902. PubMed ID: 32623319
[TBL] [Abstract][Full Text] [Related]
4. Protein arginine methyltransferase 5-mediated arginine methylation stabilizes Kruppel-like factor 4 to accelerate neointimal formation.
Liu H; Dong X; Jia K; Yuan B; Ren Z; Pan X; Wu J; Li J; Zhou J; Wang RX; Qu L; Sun J; Pan LL
Cardiovasc Res; 2023 Sep; 119(11):2142-2156. PubMed ID: 37201513
[TBL] [Abstract][Full Text] [Related]
5. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
6. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
Wang X; Qiu T; Wu Y; Yang C; Li Y; Du G; He Y; Liu W; Liu R; Chen CH; Shi Y; Pan J; Zhou J; Jiang D; Chen C
Cell Death Differ; 2021 Oct; 28(10):2931-2945. PubMed ID: 33972717
[TBL] [Abstract][Full Text] [Related]
7. PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer.
Wang Z; Kong J; Wu Y; Zhang J; Wang T; Li N; Fan J; Wang H; Zhang J; Ling R
Breast Cancer Res Treat; 2018 Apr; 168(2):531-542. PubMed ID: 29185119
[TBL] [Abstract][Full Text] [Related]
8. ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.
Zou H; Chen H; Zhou Z; Wan Y; Liu Z
Cancer Lett; 2019 Dec; 467():19-28. PubMed ID: 31563563
[TBL] [Abstract][Full Text] [Related]
9. Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance.
Zhou Z; Song X; Chi JJ; Gius DR; Huang Y; Cristofanilli M; Wan Y
Cell Signal; 2020 Jun; 70():109574. PubMed ID: 32084531
[TBL] [Abstract][Full Text] [Related]
10. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
11. The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.
Du W; Amarachintha S; Erden O; Wilson A; Pang Q
Oncotarget; 2016 Sep; 7(37):60005-60020. PubMed ID: 27507053
[TBL] [Abstract][Full Text] [Related]
12. Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis.
Hu D; Zhou Z; Davidson NE; Huang Y; Wan Y
J Biol Chem; 2012 Apr; 287(17):13584-97. PubMed ID: 22389506
[TBL] [Abstract][Full Text] [Related]
13. The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.
Rengasamy M; Zhang F; Vashisht A; Song WM; Aguilo F; Sun Y; Li S; Zhang W; Zhang B; Wohlschlegel JA; Walsh MJ
Nucleic Acids Res; 2017 Nov; 45(19):11106-11120. PubMed ID: 28977470
[TBL] [Abstract][Full Text] [Related]
14. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor.
Mounir Z; Korn JM; Westerling T; Lin F; Kirby CA; Schirle M; McAllister G; Hoffman G; Ramadan N; Hartung A; Feng Y; Kipp DR; Quinn C; Fodor M; Baird J; Schoumacher M; Meyer R; Deeds J; Buchwalter G; Stams T; Keen N; Sellers WR; Brown M; Pagliarini RA
Elife; 2016 May; 5():. PubMed ID: 27183006
[TBL] [Abstract][Full Text] [Related]
15. PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis.
Yin S; Liu L; Brobbey C; Palanisamy V; Ball LE; Olsen SK; Ostrowski MC; Gan W
Nat Commun; 2021 Jun; 12(1):3444. PubMed ID: 34103528
[TBL] [Abstract][Full Text] [Related]
16. PRMT5-mediated homologous recombination repair is essential to maintain genomic integrity of neural progenitor cells.
Wang YJ; Cao JB; Yang J; Liu T; Yu HL; He ZX; Bao SL; He XX; Zhu XJ
Cell Mol Life Sci; 2024 Mar; 81(1):123. PubMed ID: 38459149
[TBL] [Abstract][Full Text] [Related]
17. PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core.
Lubyova B; Hodek J; Zabransky A; Prouzova H; Hubalek M; Hirsch I; Weber J
PLoS One; 2017; 12(10):e0186982. PubMed ID: 29065155
[TBL] [Abstract][Full Text] [Related]
18. ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancer.
Im H; Baek HJ; Yang E; Kim K; Oh SK; Lee JS; Kim H; Lee JM
Cancer Sci; 2023 Jan; 114(1):187-200. PubMed ID: 36114756
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.
Chiang K; Zielinska AE; Shaaban AM; Sanchez-Bailon MP; Jarrold J; Clarke TL; Zhang J; Francis A; Jones LJ; Smith S; Barbash O; Guccione E; Farnie G; Smalley MJ; Davies CC
Cell Rep; 2017 Dec; 21(12):3498-3513. PubMed ID: 29262329
[TBL] [Abstract][Full Text] [Related]
20. New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapy.
Zhou Z; Huang F; Shrivastava I; Zhu R; Luo A; Hottiger M; Bahar I; Liu Z; Cristofanilli M; Wan Y
EMBO Mol Med; 2020 Dec; 12(12):e12391. PubMed ID: 33231937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
